Sleep Apnea Devices Market by Type, Therapeutic (PAP (CPAP, APAP, BPAP) Facial Interfaces, Oral Appliances, Accessories), Diagnostic (PSG, Oximeter, Actigraphy Systems), End User (Sleep Laboratories & Hospitals, Home Care Settings) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The sleep apnea devices market is projected to reach USD 10.2 billion by 2028 from USD 7.1 billion in 2021, at a CAGR of 6.9% during the forecast period.
The large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, and an increasing number of companies venturing into the sleep apnea market are some of the factors that have supported long-term expansion for sleep apnea devices market.
Sleep Apnea Devices Market is segmented into type, end-user, and geography
The type segment is segmented into therapeutic devices and diagnostic devices
The end-user segment is segmented into Sleep Laboratories & Hospitals and Home Care Settings/Individuals
Geographically, Sleep Apnea Devices Market is sub-segmented into North America, Europe, Asia-Pacific, Middle East, and Africa and South America, and insights are provided for each region and major countries within the regions
Key players in Sleep Apnea Devices Market are ResMed (US), Koninklijke Philips N.V. (Netherlands), Fisher & Paykel Healthcare (New Zealand), Inspire Medical Systems, Inc. (the US), Löwenstein Medical Technology GmbH + Co. K.G. (Germany), SomnoMed (US), Oventus Medical (Australia), Compumedics (Australia), Nihon Kohden (Japan), Natus Medical (US), Itamar Medical (Israel), Whole You, Inc. (the US), Drive DeVilbiss Healthcare (US), BMC Medical Co. Ltd. (China), BRAEBON Medical (Canada), Invacare Homecare (US), Nidek Medical India (India), Curative Medical (US), LivaNova (UK) Panthera Dental (Canada), and Myerson LLC (US)
Report Feature |
Descriptions |
---|---|
Market Revenue In 2021 |
USD 7.1 billion |
Growth Rate |
CAGR of 6.9% during the forecasting period, 2021-2026 |
Historical Data |
2018-2019 |
Forecast Years |
2021-2026 |
Base Year |
2020 |
Units Considered |
Revenue in USD billion and CAGR from 2021 to 2028 |
Report Segmentation |
Type, End-User, and Geography |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and the Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
ResMed (US), Koninklijke Philips N.V. (Netherlands), Fisher & Paykel Healthcare (New Zealand), Inspire Medical Systems, Inc. (US), Löwenstein Medical Technology GmbH + Co. K.G. (Germany), SomnoMed (US), Oventus Medical (Australia), Compumedics (Australia), Nihon Kohden (Japan), Natus Medical (US), Itamar Medical (Israel), Whole You, Inc. (US), Drive DeVilbiss Healthcare (US), BMC Medical Co. Ltd. (China), BRAEBON Medical (Canada), Invacare Homecare (US), Nidek Medical India (India), Curative Medical (US), LivaNova (UK) Panthera Dental (Canada), and Myerson LLC (US) |
Available Customization |
In addition to the market data for Sleep Apnea Devices Market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement. |